2012-03-19

av SG Cho · 2017 · Citerat av 14 — The first standard procedure for F-18 FDG PET was completed in 2013 [1]. Besides, the preliminary data of diagnostic reference levels (DRLs) for nuclear

2020-09-01 Purpose Residual lesions after chemotherapy are frequent in metastatic seminoma. Watchful waiting is recommended for lesions < 3 cm as well as for fluorodeoxyglucose (FDG) positron emission tomography (PET)–negative lesions ≥ 3 cm. Information on the optimal management of PET-positive residual lesions ≥ 3 cm is lacking. Patients and Methods We retrospectively identified 90 patients with 2009-07-10 Hepatocellular carcinoma with positive 18 F-fluorodeoxyglucose uptake on positron emission tomography.

Data of 193 consecutive patients who had undergone cryoablation for invasive ductal carcinoma or ductal carcinoma in situ ≤ 15 mm without a history of ipsilateral breast cancer, synchronous ipsilateral lesion, and with estrogen 18 F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is a diagnostic imaging modality in GCA that can be used to detect abnormal metabolic activity within the walls of large arteries as a surrogate for vascular inflammation [ 6 ]. Positron emission tomography (PET) with computed tomography (CT) using [18 F]fluorodeoxyglucose (FDG) is reliable in detecting lymph node metastases in HNSCC. 12-17 It has been reported that PET imaging is cost effective for staging patients with N0 neck. 18 Most of the data on PET/CT in the N0 neck is single institutional and retrospective.

[18F]fluoro-2-deoxy-D-glucose (FDG) is a glucose analogue radiopharmaceutical used in positron emission tomography (PET) to trace glucose metabolism.

Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer R.M. Subramaniam , M. Truong , P. Peller , O. Sakai , G. Mercier American Journal of Neuroradiology Apr 2010, 31 (4) 598-604; DOI: 10.3174/ajnr.A1760

Fluorodeoxyglucose-positron-emission tomography, single-photon emission tomography, and structural MR imaging for prediction of rapid conversion to Alzheimer disease in patients with mild cognitive impairment: a meta-analysis. AJNR Am J Neuroradiol. 2009 Feb;30 (2):404-10. doi: 10.3174/ajnr.A1357. Objectives: We retrospectively assessed the diagnostic utility of dedicated positron emission tomography (PET) and hybrid PET-computed tomography (CT) scans with [F-18]fluorodeoxyglucose (FDG) in the imaging evaluation of patients with known or suspected recurrent and metastatic cholangiocarcinoma. Methods: The study group included 24 patients (13 males and 11 females; age range, 34-75 years) with known or suspected recurrent and metastatic cholangiocarcinoma.

Fluorodeoxyglucose–Positron-Emission Tomography Imaging of Head and Neck Squamous Cell Cancer R.M. Subramaniam , M. Truong , P. Peller , O. Sakai , G. Mercier American Journal of Neuroradiology Apr 2010, 31 (4) 598-604; DOI: 10.3174/ajnr.A1760 Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. A 45-year-old man presented with a progressive transverse spinal cord syndrome. MRI scanning revealed bitemporal and multiple spinal lesions with significant enhancement after gadolinium administration mimicking an acute disseminated Positron emission tomography (PET) is a nuclear medicine procedure based on the measurement of positron emission from radiolabelled tracer molecules. These radiotracers allow biologic processes to be measured and whole body images to be obtained which demonstrates sites of radiotracer accumulation.
Belid lighting

B, Axial PET/CT imaging revealed diffuse hypermetabolic nodular thickening with a maximum standardized uptake value (SUV max) of 14.2 in the pericardium (arrow). Aman Sharma, Rajender Kumar, Adarsh MB, G S R S N K Naidu, Vikas Sharma, Apurva Sood, Varun Dhir, Roshan Verma, Harmandeep Singh, Anish Bhattacharya, Sanjay Jain, Bhagwant Rai Mittal, Fluorodeoxyglucose positron emission tomography/computed tomography in the diagnosis, assessment of disease activity and therapeutic response in relapsing polychondritis, Rheumatology, Volume 59, Issue 1, January Hepatocellular carcinoma with positive 18 F-fluorodeoxyglucose uptake on positron emission tomography. The hepatocellular carcinoma (diameter, 3.0 cm) in segment 5 exhibits staining during the arterial phase of contrast computed tomography (a) and washout during the equilibrium phase (b). Clinical application of dynamic 18F-fluorodeoxyglucose positron-emission tomography / computed tomography in the differential diagnoses of musculoskeletal lesions Takayoshi Shinya1, 2, 3, Yoichi Otomi 1, Toshihiko Nishisho 4, Bettina Beuthien-Baumann2, Saho Irahara1, Michiko Kubo1, Hideki Otsuka5, Yoshimi Bando 6, Koichi Sairyo4, and Masafumi To document 18F-Fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) findings after percutaneous cryoablation for early breast cancer. Data of 193 consecutive patients who had undergone cryoablation for invasive ductal carcinoma or ductal carcinoma in situ ≤ 15 mm without a history of ipsilateral breast cancer, synchronous ipsilateral lesion, and with estrogen Although the number of clinical applications for fluorine-18 fluorodeoxyglucose (18 F-FDG) cardiac positron emission tomography (PET) has continued to grow, there remains a lack of consensus regarding the ideal method of suppressing normal myocardial glucose utilization for image optimization.

membrane antigene FDG is the work horse of PET imaging, and is readily available on a day-to-day basis. Philips has a wide range of CT and PET/CT systems, 27 in total, that comply Reduced lung cancer mortality with low dose computed tomographic screening. A major challenge of F18-fluorodeoxyglucose positron emission tomography av L Axelsson — Positron-Emission Tomography: An imaging technique using compounds labelled The role of fluorodeoxyglucose positron emission tomography in cervical The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose Däremot rekommenderas att FDG-.
Arvslottens storlek

18F-FDG (fluorodeoxyglucose), which when injected into a patient's body helps the Positron Emission Tomography (PET-CT) scanner pick

Fluorodeoxyglucose positron emission tomography (FDG-PET) is useful in the diagnosis of neurosarcoidosis. A 45-year-old man presented with a progressive transverse spinal cord syndrome. MRI scanning revealed bitemporal and multiple spinal lesions with significant enhancement after gadolinium administration mimicking an acute disseminated encephalomyelitis. Our objective was to examine associations between glucose metabolism, as measured by (18)F-fluorodeoxyglucose positron emission tomography (FDG PET), and age and to evaluate the impact of carriage of an apolipoprotein E (APOE) ε4 allele on glucose metabolism and on the associations between glucose metabolism and age.

18-Fluorodeoxyglucose (FDG-PET/CT) is an established imaging modality that has been proven to be of benefit in the management of aggressive B-cell

RA patients (n = 119) without known cardiovascular disease underwent cardiac 18‐fluorodeoxyglucose (FDG) positron emission tomography with computed tomography (PET‐CT).

2002-12-15 · Whole body fluorodeoxyglucose positron emission tomography (FDG-PET) revealed multiple hypermetabolic hilar and mediastinal foci and spinal cord hypermetabolism at the site of MRI abnormality. Temporal lobe MRI lesions were hypometabolic. Treglia G, Sadghi R, Annunziata S et al: Diagnostic performance of fluorine-18-fluorodeoxyglucose positron emission tomography in the postchemotherapy management of patients with seminoma: Systematic review and meta-analysis. Biomed Res Int 2014: 852681, 2014 Crossref, Medline, Google Scholar: 16. 18F-fluorodeoxyglucose positron emission tomography/computed tomography enables the detection of recurrent same-site deep vein thrombosis by illuminating recently formed, neutrophil-rich thrombus. Circulation.